Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes
NCT ID: NCT03473795
Last Updated: 2025-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
7566 participants
OBSERVATIONAL
2018-03-16
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Additionally, the investigators aim to describe the gut microbiome community diversity of a cohort of community dwelling Nigerians and compare with CRC patients in Nigerian and at MSK. We will collect stool for microbiome and metabolomic analysis from community dwelling persons in the catchment area of ARGO facilities in Nigeria while contemporaneously administering an extensive medical and environmental exposure questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiometabolic Disease Risk Factors in Cameroon
NCT06957548
Potential Effectiveness of the Diabetes Prevention Program in the Peri-urban Area of Bamako, Mali
NCT05260879
NUTRITION MATTERS: A Food is Medicine Intervention for African-American Adults With Multiple Chronic Conditions
NCT06933940
A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program
NCT05144737
Nutrition Education
NCT00005728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy participants and participants diagnosed with NCDs
This protocol will entail prospective collection of data on healthy participants and participants diagnosed with NCDs managed at collaborating institutions in SSA. Information to be obtained includes socio-demographic data, risk factors, disease-specific data, investigation and treatment details, as well as findings during follow-up. Particular reference will be made to outcome measures such as local and distant recurrence, survival and mortality. Follow-up data will be updated during clinic visits and also via phone calls.
Questionnaire forms
The questionnaires will include information such as socio-demographic data, risk factors, disease specific data, investigation and treatment details as well as findings during followup. Particular reference will be made to outcome measures such as local and distant recurrence, survival and mortality.
Bio-specimen samples
Samples can include tissue, blood, urine, saliva, hair and nail clipping.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire forms
The questionnaires will include information such as socio-demographic data, risk factors, disease specific data, investigation and treatment details as well as findings during followup. Particular reference will be made to outcome measures such as local and distant recurrence, survival and mortality.
Bio-specimen samples
Samples can include tissue, blood, urine, saliva, hair and nail clipping.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspected or confirmed diagnosis of a non-communicable disease. OR
* Healthy volunteers/no confirmed diagnosis for comparison.
Exclusion Criteria
* Participants under the age of 18
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Johns Hopkins University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
T. Peter Kingham, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
National Hospital of Abuja (Data collection only)
Abuja, Central Business District, Nigeria
Lagos State University Teaching Hospital
Idi-Araba, Lagos, Nigeria
Olabisis Onabanjo University Teaching Hospital
Sagamu, Ogun State, Nigeria
Federal Medical Centre Owo
Owo, Ondo State, Nigeria
University College Hospital
Ibadan, Oyo State, Nigeria
Ladoke Akintola University of Technology
Ogbomoso, Oyo State, Nigeria
University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu
Enugu, , Nigeria
Lagos State University Teaching Hospital
Ikeja, , Nigeria
Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC)
Ile-Ife, , Nigeria
University of Ilorin Teaching Hospitals
Ilorin, , Nigeria
University of Maiduguri Teaching Hospital (Data collection only)
Maiduguri, , Nigeria
Ondo State Trauma and Surgical Centre
Ondo, , Nigeria
Federal Medical Centre Owo
Owo, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.